Cargando…
Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging
Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility of serum inflammatory markers interleukin-6 (IL-6), C reactive protein (CRP), and ferritin (Roche, Indianapolis, IN), and SARS-CoV-2 immunoglobulin G (IgG), immuno...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191995/ https://www.ncbi.nlm.nih.gov/pubmed/34111164 http://dx.doi.org/10.1371/journal.pone.0252818 |
_version_ | 1783705964646498304 |
---|---|
author | Schaefer, Ernst J. Dulipsingh, Latha Comite, Florence Jimison, Jessica Grajower, Martin M. Lebowitz, Nathan E. Lang, Maxine Geller, Andrew S. Diffenderfer, Margaret R. He, Lihong Breton, Gary Dansinger, Michael L. Saida, Ben Yuan, Chong |
author_facet | Schaefer, Ernst J. Dulipsingh, Latha Comite, Florence Jimison, Jessica Grajower, Martin M. Lebowitz, Nathan E. Lang, Maxine Geller, Andrew S. Diffenderfer, Margaret R. He, Lihong Breton, Gary Dansinger, Michael L. Saida, Ben Yuan, Chong |
author_sort | Schaefer, Ernst J. |
collection | PubMed |
description | Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility of serum inflammatory markers interleukin-6 (IL-6), C reactive protein (CRP), and ferritin (Roche, Indianapolis, IN), and SARS-CoV-2 immunoglobulin G (IgG), immunoglobulin M (IgM), and neutralizing antibodies (Diazyme, Poway, CA). In controls, non-hospitalized subjects, and hospitalized subjects assessed for SARS-CoV-2 RNA (n = 278), median IgG levels in arbitrary units (AU)/mL were 0.05 in negative subjects, 14.83 in positive outpatients, and 30.61 in positive hospitalized patients (P<0.0001). Neutralizing antibody levels correlated significantly with IgG (r = 0.875; P<0.0001). Having combined values of IL-6 ≥10 pg/mL and CRP ≥10 mg/L occurred in 97.7% of inpatients versus 1.8% of outpatients (odds ratio 3,861, C statistic 0.976, P = 1.00 x 10(−12)). Antibody or ferritin levels did not add significantly to predicting hospitalization. Antibody testing in family members and contacts of SARS-CoV-2 RNA positive cases (n = 759) was invaluable for case finding. Persistent IgM levels were associated with chronic COVID-19 symptoms. In 81,624 screened subjects, IgG levels were positive (≥1.0 AU/mL) in 5.21%, while IgM levels were positive in 2.96% of subjects. In positive subjects median IgG levels in AU/mL were 3.14 if <30 years of age, 4.38 if 30–44 years of age, 7.89 if 45–54 years of age, 9.52 if 55–64 years of age, and 10.64 if ≥65 years of age (P = 2.96 x 10(−38)). Our data indicate that: 1) combined IL-6 ≥10 pg/mL and CRP ≥10 mg/L identify SARS-CoV-2 positive subjects requiring hospitalization; 2) IgG levels were significantly correlated with neutralizing antibody levels with a wide range of responses; 3) IgG levels have significant utility for case finding in exposed subjects; 4) persistently elevated IgM levels are associated with chronic symptoms; and 5) IgG levels are significantly higher in positive older subjects than their younger counterparts. |
format | Online Article Text |
id | pubmed-8191995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-81919952021-06-10 Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging Schaefer, Ernst J. Dulipsingh, Latha Comite, Florence Jimison, Jessica Grajower, Martin M. Lebowitz, Nathan E. Lang, Maxine Geller, Andrew S. Diffenderfer, Margaret R. He, Lihong Breton, Gary Dansinger, Michael L. Saida, Ben Yuan, Chong PLoS One Research Article Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility of serum inflammatory markers interleukin-6 (IL-6), C reactive protein (CRP), and ferritin (Roche, Indianapolis, IN), and SARS-CoV-2 immunoglobulin G (IgG), immunoglobulin M (IgM), and neutralizing antibodies (Diazyme, Poway, CA). In controls, non-hospitalized subjects, and hospitalized subjects assessed for SARS-CoV-2 RNA (n = 278), median IgG levels in arbitrary units (AU)/mL were 0.05 in negative subjects, 14.83 in positive outpatients, and 30.61 in positive hospitalized patients (P<0.0001). Neutralizing antibody levels correlated significantly with IgG (r = 0.875; P<0.0001). Having combined values of IL-6 ≥10 pg/mL and CRP ≥10 mg/L occurred in 97.7% of inpatients versus 1.8% of outpatients (odds ratio 3,861, C statistic 0.976, P = 1.00 x 10(−12)). Antibody or ferritin levels did not add significantly to predicting hospitalization. Antibody testing in family members and contacts of SARS-CoV-2 RNA positive cases (n = 759) was invaluable for case finding. Persistent IgM levels were associated with chronic COVID-19 symptoms. In 81,624 screened subjects, IgG levels were positive (≥1.0 AU/mL) in 5.21%, while IgM levels were positive in 2.96% of subjects. In positive subjects median IgG levels in AU/mL were 3.14 if <30 years of age, 4.38 if 30–44 years of age, 7.89 if 45–54 years of age, 9.52 if 55–64 years of age, and 10.64 if ≥65 years of age (P = 2.96 x 10(−38)). Our data indicate that: 1) combined IL-6 ≥10 pg/mL and CRP ≥10 mg/L identify SARS-CoV-2 positive subjects requiring hospitalization; 2) IgG levels were significantly correlated with neutralizing antibody levels with a wide range of responses; 3) IgG levels have significant utility for case finding in exposed subjects; 4) persistently elevated IgM levels are associated with chronic symptoms; and 5) IgG levels are significantly higher in positive older subjects than their younger counterparts. Public Library of Science 2021-06-10 /pmc/articles/PMC8191995/ /pubmed/34111164 http://dx.doi.org/10.1371/journal.pone.0252818 Text en © 2021 Schaefer et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Schaefer, Ernst J. Dulipsingh, Latha Comite, Florence Jimison, Jessica Grajower, Martin M. Lebowitz, Nathan E. Lang, Maxine Geller, Andrew S. Diffenderfer, Margaret R. He, Lihong Breton, Gary Dansinger, Michael L. Saida, Ben Yuan, Chong Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging |
title | Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging |
title_full | Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging |
title_fullStr | Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging |
title_full_unstemmed | Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging |
title_short | Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging |
title_sort | corona virus disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191995/ https://www.ncbi.nlm.nih.gov/pubmed/34111164 http://dx.doi.org/10.1371/journal.pone.0252818 |
work_keys_str_mv | AT schaeferernstj coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT dulipsinghlatha coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT comiteflorence coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT jimisonjessica coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT grajowermartinm coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT lebowitznathane coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT langmaxine coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT gellerandrews coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT diffenderfermargaretr coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT helihong coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT bretongary coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT dansingermichaell coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT saidaben coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging AT yuanchong coronavirusdisease19serologyinflammatorymarkershospitalizationscasefindingandaging |